ATE388149T1 - Neue azaindol-thiazolinone als krebsmittel - Google Patents

Neue azaindol-thiazolinone als krebsmittel

Info

Publication number
ATE388149T1
ATE388149T1 AT05796364T AT05796364T ATE388149T1 AT E388149 T1 ATE388149 T1 AT E388149T1 AT 05796364 T AT05796364 T AT 05796364T AT 05796364 T AT05796364 T AT 05796364T AT E388149 T1 ATE388149 T1 AT E388149T1
Authority
AT
Austria
Prior art keywords
thiazolinones
azaindol
new
cancer medicine
cancer
Prior art date
Application number
AT05796364T
Other languages
English (en)
Inventor
Shaoqing Chen
Achyutharao Sidduri
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE388149T1 publication Critical patent/ATE388149T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT05796364T 2004-10-14 2005-10-05 Neue azaindol-thiazolinone als krebsmittel ATE388149T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61867204P 2004-10-14 2004-10-14

Publications (1)

Publication Number Publication Date
ATE388149T1 true ATE388149T1 (de) 2008-03-15

Family

ID=35423339

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05796364T ATE388149T1 (de) 2004-10-14 2005-10-05 Neue azaindol-thiazolinone als krebsmittel

Country Status (15)

Country Link
US (1) US7247727B2 (de)
EP (1) EP1805175B1 (de)
JP (1) JP2008516903A (de)
KR (1) KR100875870B1 (de)
CN (1) CN100569773C (de)
AT (1) ATE388149T1 (de)
AU (1) AU2005293831B2 (de)
BR (1) BRPI0518158A (de)
CA (1) CA2582986A1 (de)
DE (1) DE602005005211T2 (de)
ES (1) ES2301066T3 (de)
MX (1) MX2007004273A (de)
PL (1) PL1805175T3 (de)
RU (1) RU2391342C2 (de)
WO (1) WO2006040049A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7371862B2 (en) * 2005-11-11 2008-05-13 Pfizer Italia S.R.L. Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
FR2907120B1 (fr) 2006-10-12 2013-01-11 Sanofi Aventis Nouveaux derives imidazolones,leur preparation a titre de medicaments,compositions pharmaceutiques,utilisation comme inhibiteurs de proteines kinases notamment cdc7
FR2926463B1 (fr) * 2008-01-22 2010-08-13 Centre Nat Rech Scient Utilisation d'inhibiteurs d'aminopeptidase ou de composes azaindole pour la prevention ou le traitement de metastases cancereuses d'origine epitheliale
US20120135989A1 (en) * 2010-06-29 2012-05-31 Crystalgenomics, Inc. Azaindole derivative
US8742113B2 (en) * 2011-03-31 2014-06-03 Sbi Biotech Co., Ltd. Furanone derivative
KR101277161B1 (ko) * 2011-07-08 2013-06-20 주식회사 엠엠테크 글라스 박형화 시스템
US9949961B2 (en) 2013-03-14 2018-04-24 Rahimdzhan Roziev Agent for the prophylaxis and/or treatment of neoplastic diseases
RU2521390C1 (ru) * 2013-03-14 2014-06-27 Общество с ограниченной ответственностью "Тиацен" Производное роданина и средство для профилактики опухолевых заболеваний
JP6569908B2 (ja) 2014-01-31 2019-09-04 カルナバイオサイエンス株式会社 抗がん剤組成物
EP4083037A4 (de) * 2019-12-26 2024-01-24 Yonsei University, University-Industry Foundation(UIF). Pyrrolidinderivat und pharmazeutische zusammensetzung zur vorbeugung oder behandlung von beta-amyloid- oder tau-protein-assoziierten krankheiten, die diese enthalten
KR20240020735A (ko) 2021-05-07 2024-02-15 카이메라 쎄라퓨틱스 인코포레이티드 Cdk2 분해제 및 그 용도
WO2026024674A1 (en) 2024-07-22 2026-01-29 Genesis Therapeutics, Inc. Methods of treating skp2-associated cancers

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996003377A1 (en) * 1994-07-27 1996-02-08 Sankyo Company, Limited Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors
KR970706813A (ko) 1994-11-10 1997-12-01 찰스 홈시 단백질 키나아제의 억제물질로서 유용한 제약용 피라졸 조성물(pharmaceutical pyrazole compositions useful as inhibitors of protein kinases)
WO1997034876A1 (en) 1996-03-15 1997-09-25 Zeneca Limited Cinnoline derivatives and use as medicine
US6569878B1 (en) 1997-10-27 2003-05-27 Agouron Pharmaceuticals Inc. Substituted 4-amino-thiazol-2-yl compounds as cyclin-dependent kinase inhibitors
US6335342B1 (en) * 2000-06-19 2002-01-01 Pharmacia & Upjohn S.P.A. Azaindole derivatives, process for their preparation, and their use as antitumor agents
WO2003028724A1 (en) * 2001-10-04 2003-04-10 Smithkline Beecham Corporation Chk1 kinase inhibitors
AU2003255528B2 (en) * 2002-07-10 2009-07-16 Merck Serono Sa Azolidinone-vinyl fused-benzene derivatives
WO2004006916A1 (en) * 2002-07-10 2004-01-22 Applied Research Systems Ars Holding Nv Use of compounds for increasing spermatozoa motility
EP1551396A1 (de) * 2002-09-26 2005-07-13 Pintex Pharmaceuticals, Inc. Pin1-modulierende verbindungen und anwendungsverfahren daf r
EP1567112B1 (de) * 2002-11-22 2008-10-15 Smithkline Beecham Corporation THIAZOLIDIN-4-ONES UM hYAK3 PROTEINEN ZU HEMMEN

Also Published As

Publication number Publication date
CA2582986A1 (en) 2006-04-20
PL1805175T3 (pl) 2008-08-29
KR20070053342A (ko) 2007-05-23
MX2007004273A (es) 2007-05-11
EP1805175A1 (de) 2007-07-11
RU2391342C2 (ru) 2010-06-10
CN100569773C (zh) 2009-12-16
US7247727B2 (en) 2007-07-24
AU2005293831A1 (en) 2006-04-20
WO2006040049A1 (en) 2006-04-20
RU2007117764A (ru) 2008-11-20
CN101039943A (zh) 2007-09-19
DE602005005211D1 (de) 2008-04-17
US20060084674A1 (en) 2006-04-20
DE602005005211T2 (de) 2009-03-19
BRPI0518158A (pt) 2008-11-04
KR100875870B1 (ko) 2008-12-26
ES2301066T3 (es) 2008-06-16
EP1805175B1 (de) 2008-03-05
AU2005293831B2 (en) 2011-01-06
JP2008516903A (ja) 2008-05-22

Similar Documents

Publication Publication Date Title
CY1118082T1 (el) Ανταγωνιστες μουσκαρινικου υποδοχεα ακετυλοχολινης
ATE525374T1 (de) Heteroarylsubstituierte pyrroloä2,3-büpyridine und pyrroloä2,3-büpyrimidine als januskinaseinhibitoren
PT2061814E (pt) Anticorpos e imunoconjugados e suas utilizações
CY1111364T1 (el) Ανταγωνιστες μουσκαρινικου υποδοχεα ακετυλοχολινης
BRPI0512235A (pt) polipeptìdeos ligadores de antìgenos e seus usos
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
DK1812895T3 (da) Stofkilde
DE602006011363D1 (de) Heteroaryl-substituierte piperidin-derivate als l-cpt1-hemmer
NL2000323A1 (nl) Pyrimidine-derivaten.
ATE415400T1 (de) Pyrazolopyridinderivate
NL1031218A1 (nl) Oxyindoolderivaten.
ATE458740T1 (de) 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
ATE388149T1 (de) Neue azaindol-thiazolinone als krebsmittel
ATE471938T1 (de) Substituierte diazaspiroä4.5üdecanderivate und deren verwendung als neurokininantagonisten
NO20050595D0 (no) Multilagdelt bronnkopling
ATE417045T1 (de) Substituierte diazaspiroä5.5üundecanderivate und deren verwendung als neurokininantagonisten
BRPI0506777A (pt) antagonistas do receptor muscarìnico da acetilcolina
IL186121A0 (en) Substituted 1,5-naphthyridine azolidinones as cdk inhibitors
ATE442366T1 (de) Oxazolidinonderivate und ihre verwendung als antibiotika
DE602006004713D1 (de) Trifluormethylbenzamidderivate und therapeutische verwendungen dafür
EP1912921A4 (de) Verbindungen auf tetraazaporphyrinbasis und deren verwendungen
ATE435865T1 (de) Als pde5-inhibitoren verwendete pyrazoloä4,3- düpyrimidin-5-ylderivate
ATE399767T1 (de) 1-phenyl- und 1-pyridylpyrazolderivate und deren verwendung als pestizide
BRPI0418466B1 (pt) conjunto de assentos de aeronave e aeronave.
CR9858A (es) Agentes antitumor (derivados de quinolina y uso como agentes antitumor)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1805175

Country of ref document: EP